Patient Recruitment/Retention White Papers & Case Studies
-
Virtual Approaches In Oncology Clinical Trials During COVID-19 And Onward
3/4/2021
Patients living with cancer are among the most vulnerable during the pandemic, but sponsors and researchers understand oncology drug development must continue. This paper discusses how COVID-19 is driving change in the oncology trial landscape and how these insights may shape the future of post-pandemic clinical development.
-
Patient Centricity And Virtualizing Technologies In A COVID-19 World
1/29/2021
As the COVID-19 pandemic rages on, clinical trial conduct is being reimagined in ways few thought possible not so long ago. Patient centricity is a growing and important movement within clinical trials. New information is constantly filtering in as to how sites are adapting to the COVID-19 era, and how patient-centric solutions are playing a growing role. The Society for Clinical Research Sites (SCRS) recently collaborated with Medidata (a Dassault Systemes Company) to conduct an online survey to measure current and anticipated levels of adoption of patient-centric tools, and the sites’ perspective on how patients have reacted to them.
-
The Growth Of Phase IV Trials And The Need To Demonstrate Effectiveness Using Electronic Patient Reported Outcomes
7/10/2020
This paper addresses and describes the growing need to satisfy the value perception of multiple stakeholders and the importance of Late Phase trials capturing Clinical Outcome Assessments (COA) and electronic Patient Reported Outcomes (ePRO) in relation to this.
-
The Impact Of ADAPTABLE: The Industry's First And Largest Fully Decentralized Clinical Megatrial
7/10/2020
Web-based application remotely manages the informed consent process, enrollment, and randomization of ADAPTABLE participants while allowing them to easily report their health outcomes throughout the study from the comfort of their homes.
-
Almac Delivers Same Day Compassionate Use Shipment For COVID-19 Patients
7/6/2020
The COVID-19 pandemic is placing sharp focus on a sponsor’s ability to meet pressing clinical supply chain timelines. Read Almac’s latest case study to learn how in one urgent situation, patients fighting COVID-19 were given fast access to potentially life-saving treatment.
-
Clinical Trial Direct To Patient And Home Health Care Services
6/8/2020
Home based services for clinical trials are playing an increasingly important role in patient retention, satisfaction and safety. At LabConnect we have over 12 years of experience supporting home based clinical trial visits. Our Direct to Patient services (DTP) and Home Health Care services (HHC) allow patients the flexibility and convenience of staying at home while participating in either traditional or virtual clinical trials.
-
Decentralized Clinical Trials Travel And Payment Solutions
5/20/2020
As the landscape of clinical trials evolves, we are beginning to see more decentralized trials where a portion or all of a study is conducted remotely. For these types of trials, ensuring patient engagement and convenience becomes even more critical. To help provide reassurance during this uncertain time, our team has reaffirmed provider safety precautions.
-
ClinCard Data-Triggered Payments
5/20/2020
As the landscape of clinical trials evolves, we are beginning to see an increased need for remote payments or payments that are triggered by a specific event, enabling participants to receive funds without travelling to the clinical. Participant reimbursements can be processed in the office or remotely via ClinCard’s data-triggered payments capability.
-
ConneX Clinical Patient Direct Service
4/11/2020
Through ConneX, Greenphire has established a global network of local and long distance travel providers. This extensive hub provides expert travel arrangement for clinical trial participants, their families and caretakers.
-
Developing Analgesia Studies: Use Of Placebo Control In The EU
2/25/2020
There is longstanding debate on the use of placebo control in clinical trials. This white paper reviews the regulatory, ethical, cultural, and even financial considerations surrounding the issue of placebo control in analgesia clinical trials.